Progress in Transplantation · 2001 · 68 citations · 9 references
MedicineHealth Services AdministrationNephrologyDialysisKidney TransplantationRenal Replacement TherapyImmunosuppression In Kidney TransplantationTransplant OutcomesBreak-even EffectsEnd-stage Kidney Disease ManagementEnd-stage Renal Disease EligibilityKidney Replacement TherapyKidney Transplant CareMedicare Savings Program EligibilityRenal Transplant CareTransplantation
Using 1998 data for 8 transplantation centers located in New York City, this study found that kidney transplantation was a more cost-effective treatment than hemodialysis for the Medicare program. The initially higher costs of transplantation were fully recouped by Medicare 2 years and 10 months after surgery. For persons who are eligible for Medicare solely due to their end-stage renal disease status, transplantation would generate average monthly savings of $3800 over dialysis for the 2 years following the break-even point. For those eligible for reasons other than end-stage renal disease, for example, the aged, the average savings would be $2400. The savings difference arises because Medicare coverage for immunosuppressants for the former group ends 36 months after transplantation.
9
A study of the quality of life and cost-utility of renal transplantation
Andreas Laupacis, Paul Keown, Nancy Pus et al. · Kidney International · 1996 · 1.2K citations · Full text
From the Health Care Financing Administration
Gail R. Wilensky · JAMA · 1991 · 635 citations